We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QFIN icon
2451
Qfin Holdings
QFIN
$1.56B
$596K ﹤0.01%
38,818
+26,765
+222% +$457K
DQ
2452
Daqo New Energy
DQ
$984M
$595K ﹤0.01%
19,670
+106
+0.5% +$3.78K
FFIC
2453
DELISTED
Flushing Financial
FFIC
$593K ﹤0.01%
45,131
+326
+0.7% +$4.56K
CARE icon
2454
Carter Bankshares
CARE
$729M
$592K ﹤0.01%
47,247
-159
-0.3% -$2.28K
CLSK icon
2455
CleanSpark
CLSK
$3.09B
$591K ﹤0.01%
155,222
+41,523
+37% +$219K
MERC icon
2456
Mercer International
MERC
$35.7M
$591K ﹤0.01%
68,883
+5,313
+8% +$45.8K
FRPH icon
2457
FRP Holdings
FRPH
$421M
$590K ﹤0.01%
21,872
+254
+1% +$7.16K
NRIX icon
2458
Nurix Therapeutics
NRIX
$2.65B
$590K ﹤0.01%
75,049
+1,993
+3% +$18.2K
HROW icon
2459
Harrow
HROW
$1.52B
$587K ﹤0.01%
40,866
+7,307
+22% +$128K
PSFE icon
2460
Paysafe
PSFE
$367M
$587K ﹤0.01%
48,913
+325
+0.7% +$3.96K
PHAT icon
2461
Phathom Pharmaceuticals
PHAT
$712M
$586K ﹤0.01%
56,537
+6,332
+13% +$86.9K
EOLS icon
2462
Evolus
EOLS
$499M
$583K ﹤0.01%
63,836
+660
+1% +$5.92K
SANA icon
2463
Sana Biotechnology
SANA
$1B
$581K ﹤0.01%
150,118
-2,732
-2% -$14.7K
CP icon
2464
Canadian Pacific Kansas City
CP
$80.6B
$580K ﹤0.01%
7,794
+215
+3% +$17.1K
ORC
2465
Orchid Island Capital
ORC
$1.3B
$579K ﹤0.01%
68,092
+4,926
+8% +$48.3K
SRDX
2466
DELISTED
Surmodics
SRDX
$579K ﹤0.01%
18,051
-70
-0.4% -$2.38K
SEI
2467
Solaris Energy Infrastructure
SEI
$3.95B
$578K ﹤0.01%
54,251
+885
+2% +$9.03K
TME icon
2468
Tencent Music
TME
$16B
$578K ﹤0.01%
90,611
-4,066
-4% -$27.1K
BLBD icon
2469
Blue Bird Corp
BLBD
$2.15B
$577K ﹤0.01%
27,017
+850
+3% +$18K
ALNT icon
2470
Allient
ALNT
$1.96B
$577K ﹤0.01%
18,646
+307
+2% +$10.6K
CCNE icon
2471
CNB Financial Corp
CCNE
$1.02B
$576K ﹤0.01%
31,833
+210
+0.7% +$3.89K
PHI icon
2472
PLDT
PHI
$4.23B
$576K ﹤0.01%
27,897
+105
+0.4% +$2.3K
PTVE
2473
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$575K ﹤0.01%
70,698
-2,352
-3% -$19.2K
NTGR icon
2474
NETGEAR
NTGR
$626M
$574K ﹤0.01%
45,566
-48,062
-51% -$637K
GMAB icon
2475
Genmab
GMAB
$19.1B
$573K ﹤0.01%
16,241
+311
+2% +$11.9K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.